VAERS reports by lot

GSK Varicella/Shingles lot 7KG39: VAERS reports

55 VAERS reports list lot 7KG39 as a GSK Varicella/Shingles vaccine, received between 2023-01-12 and 2024-08-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
55
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction823%
General / Systemic (non-local)720%
Neurological514%
Gastrointestinal411%
Dermatological (non-injection-site)39%
Cardiac / Cardiovascular26%
Allergic / Anaphylactic26%
Musculoskeletal26%
Respiratory13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Ohio38
California4
Texas2
Virginia2
West Virginia2
Alaska1
North Carolina1
Michigan1
Mississippi1
Minnesota1
Arizona1
Oklahoma1

Reports by month received

2023-013
2023-024
2023-032
2023-0439
2023-062
2023-071
2023-112
2024-051
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.